Prediction of oral drug absorption in humans by theoretical passive absorption model

https://doi.org/10.1016/j.ijpharm.2005.01.005Get rights and content

Abstract

The purpose of the present study was to examine the oral drug absorption predictability of the theoretical passive absorption model (TPAM). As chemical descriptors of drugs, the octanol/buffer distribution coefficient at pH 6.0 (Dow), intrinsic octanol–water partition coefficient (Pow), pKa, and molecular weight (MW) were calculated from the chemical structure. Total passive intestinal membrane permeation consists of transcellular, paracellular and unstirred water layer (UWL) permeation. Transcellular permeation was modeled based on the pH-partition hypothesis with correction for cationic species permeation, and the independent variables were Dow, Pow, and pKa. Paracellular permeation was modeled as a size-restricted diffusion within a negative electrostatic field-of-force, and the independent variables were MW and pKa. UWL permeation was modeled as diffusion across a water layer, and the independent variable was MW. Cationic species permeation in the transcellular permeation model and the effect of a negative electric field-of-force in the paracellular permeation model were the extensions to the previous TPAM. The coefficients of the paracellular and UWL permeation models were taken from the literature. A data set of 258 compounds with observed values of Fa% (the fraction of a dose absorbed in humans) taken from the literature was employed to optimize four fitting coefficients in the transcellular permeation model. The TPAM predicted Fa%, with root mean square errors of 15–21% and a correlation coefficient (CC) of 0.78–0.88. In addition, the TPAM predicted the effective human intestinal membrane permeability with a CC of 0.67–0.77, as well as the contribution of paracellular permeation. The TPAM was found to predict oral absorption from the chemical structure of drugs with adequate predictability for usage in drug discovery.

Introduction

In the recent drug discovery and development process, in silico prediction of absorption, metabolism, distribution, and excretion (ADME) is recognized as a key technique (van de Waterbeemd and Gifford, 2003). Among ADME properties, oral absorption has been most intensively investigated for in silico prediction. As an oral absorption parameter, the fraction of a dose absorbed in humans (Fa%), the effective intestinal membrane permeability in humans (Peff), Caco-2 permeability, etc., have been studied as targets for in silico prediction (Wessel et al., 1998, Winiwarter et al., 1998, Zhao et al., 2001, Yamashita et al., 2002). Oral absorption from a solid dosage is determined by the dissolution rate, the solubility, and the intestinal membrane permeability (Yu and Amidon, 1999). Intestinal membrane permeation consists of transcellular, paracellular, and unstirred water layer (UWL) permeation. Most of the previous in silico prediction studies scrambled these absorption processes, and the contribution of each process cannot be predicted. In addition, the previous in silico methods often used descriptors that are not easy to translate into better drug design.

Previously, the theoretical passive absorption model (TPAM) had been proposed for describing passive intestinal membrane permeation (Camenisch et al., 1996, Camenisch et al., 1998). The TPAM consists of three partial models, i.e., the transcellular, paracellular and UWL permeation models. The TPAM is beneficial for qualitatively comprehending the membrane permeation from the viewpoint of both the physiology of the intestine and the chemical structure of drugs. However, the predictability of the TPAM for the oral absorption in humans has not been examined. The purpose of the present study was to quantitatively examine the oral drug absorption predictability of the TPAM.

Section snippets

Transcellular permeation model

Passive transcellular permeation is diffusion across a lipid bilayer. Therefore, the permeability depends on the lipophilicity of the permeant. In the previous TPAM, the passive transcellular permeability (Ptrans) was expressed by the 1-octanol/buffer distribution coefficient (Dow), with the help of so-called Collander equations (Collander, 1950, Collander, 1951, Camenisch et al., 1998).Ptrans=aDowα

To reflect the pH at the intestinal epithelial membrane surface, the Dow at pH 6.0 was employed (

Results and discussion

Previously, Wenlock et al. (2003) reported that the mean log Dow (pH 7.4) of the marketed oral drugs was 1.0 and the standard deviation was 3.4. Distribution of log Dow (pH 7.4) and electrical charge of drugs collected in this study (N = 343) is shown in Fig. 1. The mean log Dow (pH 7.4) was −0.41 and the standard deviation was 3.3. After excluding efflux substrates, intestinal metabolism substrates and low solubility drugs, the mean log Dow (pH 7.4) was −0.62 and the standard deviation was 2.8 (N = 

References (85)

  • H. Lennernäs et al.

    The effect of amiloride on the in vivo effective permeability of amoxicillin in human jejunum: experience from a regional perfusion technique

    Eur. J. Pharm. Sci.

    (2002)
  • G. Nicolaos et al.

    Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion

    Int. J. Pharm.

    (2003)
  • S. Orlowski et al.

    Bromocriptine Modulates P-Glycoprotein Function

    Biochem. Biophys. Res. Commun.

    (1998)
  • J.F. Poschet et al.

    Characterisation of penicillin-G uptake in rabbit small-intestinal brush-border membrane vesicles

    Biochem. Biophys. Acta

    (1996)
  • P. Proulx

    Structure-function relationships in intestinal brush border membranes

    Biochem. Biophys. Acta

    (1991)
  • L.S. Schanker et al.

    Interaction of purines with the pyrimidine transport process of the small intestine

    Biochem. Pharmacol.

    (1963)
  • K. Sugano et al.

    High throuput prediction of oral absorption: improvement of the composition of the lipid solution used in parallel artificial membrane permeation assay

    J. Biomol. Screen.

    (2001)
  • K. Sugano et al.

    Prediction of passive intestinal absorption using bio-mimetic artificial membrane permeation assay and the paracellular pathway model

    Int. J. Pharm.

    (2002)
  • K. Sugano et al.

    Prediction of human intestinal permeability using artificial membrane permeability

    Int. J. Pharm.

    (2003)
  • K. Sugano et al.

    Permeation characteristics of a hydrophilic basic compound across a bio-mimetic artificial membrane

    Int. J. Pharm.

    (2004)
  • I. Tamai et al.

    Carrier-mediated approaches for oral drug delivery

    Adv. Drug Deliv. Rev.

    (1996)
  • A. Tsuji et al.

    Carbenicillin prodrugs: kinetics of intestinal absorption competing degradation of the alpha-esters of carbenicillin and prediction of prodrug absorbability from quantitative structure-absorption rate relationship

    J. Pharm. Sci.

    (1982)
  • E. Walter et al.

    HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro–in vivo correlation with permeability data from rats and humans

    J. Pharm. Sci.

    (1996)
  • D. Winne

    Effect of villosity and distension on the absorptive and secretory flux in the small intestine

    J. Theor. Biol.

    (1989)
  • S.H. Yalkowsky et al.

    Solubility and partitioning. I. solubility of non-electrolytes in water

    J. Pharm. Sci.

    (1980)
  • S. Yamashita et al.

    Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells

    Eur. J. Pharm. Sci.

    (2000)
  • F. Yamashita et al.

    Quantitative structure/property relationship analysis of Caco-2 permeability using a genetic algorithm-based partial least squares method

    J. Pharm. Sci.

    (2002)
  • L.X. Yu et al.

    A compartmental absorption and transit model for estimating oral drug absorption

    Int. J. Pharm.

    (1999)
  • Y.H. Zhao et al.

    Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors

    J. Pharm. Sci.

    (2001)
  • C.G. Adair et al.

    The effect of dietary amino acids on the gastrointestinal absorption of melphalan and chlorambucil

    Cancer Chemother. Pharmacol.

    (1987)
  • D. Adam et al.

    Pharmacokinetics of ceftizoxime with and without probenecid

    Arzneimittel-Forschung

    (1982)
  • A. Adson et al.

    Quantitative approaches to delineate paracellular diffusion in cultured epithelial cell monolayers

    J. Pharm. Sci.

    (1994)
  • A. Adson et al.

    Passive diffusion of weak organic electolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular and paracellular barriers

    Pharm. Res.

    (1995)
  • A. Avdeef

    Physicochemical profiling (solubility, permeability and charge state)

    Curr. Top. Med. Chem.

    (2001)
  • A. Avdeef

    Absorption and drug development solubility

    Permeability and Charge State

    (2003)
  • K. Balon et al.

    Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption

    Pharm. Res.

    (1999)
  • I. Behrens et al.

    Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells

    Pharm. Res.

    (2001)
  • W.L. Chiou et al.

    Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats

    Pharm. Res.

    (1998)
  • W.L. Chiou et al.

    Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans

    Pharm. Res.

    (2000)
  • W.L. Chiou et al.

    A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans

    Int. J. Clin. Pharmacol. Ther.

    (2001)
  • S. Chong et al.

    In vitro permeability through Caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system

    Pharm. Res.

    (1996)
  • R. Collander

    The distribution of organic compounds between iso-butanol and water

    Acta Chem. Scand.

    (1950)
  • Cited by (55)

    • In silico model-based exploration of the applicability of parallel artificial membrane permeability assay (PAMPA) to screen chemicals of environmental concern

      2022, Environment International
      Citation Excerpt :

      We additionally considered stagnant boundary layers at the interface between donor and membrane and the interface between acceptor and membrane. First, the thickness of a boundary layer on the side of the water-based solvent, also known as the unstirred water layer (UWL) (Avdeef et al., 2004; Bermejo et al., 2004; Obata et al., 2005), is variable and a function of the frequency of stirring (Avdeef et al., 2004; Ruell et al., 2003). The UWL has a thickness of 0.2 cm when unstirred, whereas vigorous stirring can reduce the UWL thickness to 30–50 µm (Avdeef et al., 2004).

    View all citing articles on Scopus

    Part of this study was presented at LogP2004 Symposium, Zurich (Sugano, K., Obata, K., Saitoh, R., Higashida, A., Hamada, H., 2004. Processing of biopharmaceutical profiling data in drug discovery).

    1

    Present address: Global Research & Development, Nagoya Laboratories, Pharmaceutical Sciences, Science and Technology, Pharmaceutical R&D, Pfizer Inc., 5-2 Taketoyo, Aichi 470-2393, Japan.

    View full text